Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors.
about
Evolving Therapies and FAK Inhibitors for the Treatment of CancerExome sequencing reveals a potential mutational trajectory and treatments for a specific pancreatic cancer patient.Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cellsTargeted therapies for gastric cancer: current status.Sequential combination therapy with flavopiridol and autocatalytic caspase-3 driven by amplified hTERT promoter synergistically suppresses human ovarian carcinoma growth in vitro and in mice.Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1).The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trial.High-throughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin.LARP7 is a potential tumor suppressor gene in gastric cancer.A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors.Flavonoids, Flavonoid Subclasses, and Esophageal Cancer Risk: A Meta-Analysis of Epidemiologic Studies.Comparative drug screening in NUT midline carcinoma.Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor-chemotherapy combinations as an anticancer strategy for solid tumors.The CDK inhibitors in cancer research and therapy.Emerging cell-cycle inhibitors for pancreatic cancer therapy.Recent advances and future trends in the targeted therapy of metastatic gastric cancer.Dinaciclib for the treatment of breast cancer.Highlights of the Latest Advances in Research on CDK Inhibitors.Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.Emerging kinase inhibitors of the treatment of gastric cancer.Emerging Therapeutic Targets for Male Germ Cell Tumors.Investigational targeted therapies for the treatment of testicular germ cell tumors.Potential Use of Flavopiridol in Treatment of Chronic Diseases.
P2860
Q28972291-6F04AB03-EE9F-4AF6-99EB-89FE2B591873Q33583509-3284E1C0-C4E3-4086-990A-AD4CCD2A1A16Q34027454-BA344FF7-083C-42D2-888C-95A9AD4F88DEQ34205672-18C57677-00C0-49F2-86E8-4EF8D6837FB7Q34997857-7CCEBCAE-43E8-41F2-BBA1-E2DB79ADC59EQ35034758-071F01B0-65EF-4800-BA8C-A4EB0B3674A3Q35931388-3DAE4B40-BF0E-4251-9766-D920F8D95682Q36140973-95177599-ECD8-4E87-BE5F-2BAD32DA756AQ36247023-758B7C41-E7A2-46F8-B768-22B02531C544Q36363971-ECBDCA79-B5EC-4350-B0F7-CCDA3A8EBB1BQ37045133-CD32025C-223E-4BAA-BD35-2F046595B999Q37632187-DC6E1D0F-B4AE-4024-B9B5-DC86C3BC0939Q37798827-4C05E1AE-44AB-495F-904B-D0C7FEF04B11Q37923861-8A519213-5D5E-4969-B1EC-F08168BC96CBQ38057759-7EE22508-95E5-49A1-B929-04F888B770D3Q38199128-6EC8FE35-6BFE-4CFA-A62E-47DB42A85E9FQ38238282-460CD75E-B937-48AB-A5D8-3DD4D611B65BQ38263222-FA5C2680-E4FD-4CD9-A06D-F47AE0C59506Q38369468-2FF6440E-2287-4DA4-8B89-57C0EA71D8A8Q38506084-194A7635-9BBD-4B4D-BAB0-7F8D84CE54A6Q38602699-402DC6FD-CD0D-4B0C-8137-D1732F6C63B1Q38861307-5B749AC7-1B9E-4FAF-A441-A455D0D5C42BQ38988581-B6CDAA88-F3A8-4D21-B8C2-F6DDEC765DF0
P2860
Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phase I study of flavopiridol ...... orin in advanced solid tumors.
@ast
Phase I study of flavopiridol ...... orin in advanced solid tumors.
@en
type
label
Phase I study of flavopiridol ...... orin in advanced solid tumors.
@ast
Phase I study of flavopiridol ...... orin in advanced solid tumors.
@en
prefLabel
Phase I study of flavopiridol ...... orin in advanced solid tumors.
@ast
Phase I study of flavopiridol ...... orin in advanced solid tumors.
@en
P2093
P2860
P50
P1476
Phase I study of flavopiridol ...... orin in advanced solid tumors.
@en
P2093
Gary K Schwartz
Heather J Dials
Lauren M Cane
Manish A Shah
Mark A Dickson
Mithat Gonen
Richard D Carvajal
Robert Lefkowitz
P2860
P304
P356
10.1158/1078-0432.CCR-09-1502
P407
P577
2009-11-24T00:00:00Z